Brandon Matthew Hayes-Lattin MD
Hematologic Oncology
Professor of Medicine, Medical Director of Hematology and Medical Oncology
Join to View Full Profile
3181 SW Sam Jackson Park Rd# L586Portland, OR 97239
Phone+1 503-494-8534
Fax+1 503-494-3257
Dr. Hayes-Lattin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Oregon Health & Science University (OHSU Health)Fellowship, Hematology and Medical Oncology, 2001 - 2004- Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 1997 - 2000
University of Washington School of MedicineClass of 1997, MD
StanfordBS, 1988 - 1992
Certifications & Licensure
OR State Medical License 1998 - 2027
WA State Medical License 2005 - 2026
American Board of Internal Medicine Hematology
Clinical Trials
- Xcellerated T CellsTM for Non-Hodgkin's Lymphoma (NHL) Patients Start of enrollment: 2004 Mar 01
- Flu/TBI in Treating Patients Not Responding to Previous Hormone Therapy Start of enrollment: 2005 Jan 01
- Fludarabine and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Metastatic Kidney Cancer That Cannot Be Removed By Surgery Start of enrollment: 2005 Jun 01
Publications & Presentations
PubMed
- 1 citationsAccess to Allogeneic Cell Transplantation Based on Donor Search Prognosis: BMT CTN 1702 Trial.Jason G Dehn, Brent Logan, Stephanie J Lee, Bronwen E Shaw, Steven Devine
Transplantation and Cellular Therapy. 2026-03-01 - ASH 2026 Guidelines for Management of Relapsed/Refractory Disease in Adolescents and Young Adults with ALL.Kristen M O'Dwyer, Lena E Winestone, Matthew C Cheung, Lydia Benitez, Barbara Buldini
Blood Advances. 2026-02-11 - Diurnal rhythm in chimeric antigen receptor T cell effectiveness in an observational study of 715 patients.Patrick G Lyons, Emily Gill, Prisha Kumar, Melissa Beasley, Brenna Park-Egan
JCI Insight. 2026-02-09
Press Mentions
What Is Causing a Rise in Early-Onset Gastrointestinal Cancers, Including Pancreatic Cancer?January 16th, 2026- The Knight Cancer Challenge’s Enduring Legacy: Celebrating a Decade of Cancer Research, Care, PreventionJune 24th, 2025
Raising Awareness of the Financial Impact of Cancer on Young Adult SurvivorsJuly 10th, 2018
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
